“It’s not a case of cannabis being all good or all bad. It depends on how people are using it, what outcomes you’re looking at, what products are being used, for what reasons, and what part of the lifespan.” — Anika Guha, Ph.D., CU Anschutz

“For most patients in the early stages of schizophrenia, symptomatic remission can be achieved using a simple treatment algorithm comprising the sequential administration of amisulpride and clozapine.” — Leucht et al, J Clin Psychiatry 2026

“Health care systems should recruit more trained psychologists and offer combinations of evidence-based pharmacotherapy and psychotherapy to patients with mood disorder, especially with suicide risk in resource-limited settings.” — Study authors, Journal of Psychiatric Research

“Evenamide has the potential to treat the symptoms of schizophrenia more broadly, addressing also those poorly managed by the currently available antipsychotics.” — Ravi Anand, MD, Therapeutic Advances in Psychopharmacology

“Provider undermines the physician’s ethical obligations, clinical integrity, and accountability, as well as trust in the patient–physician relationship.” — ACP Board of Regents

“If the systems of the site are compromised and being held for ransom, there would be no way to continue that trial, and [it would likely be] impossible to participate in other trials.” — Jeff Patton, MD, OneOncology